Company and Mission

NeuVitas Therapeutics Inc. is a preclinical biotechnology company bringing transformative change to the field of  Alzheimer's disease. Lead assets are held in four pipeline portfolios: pharmacotherapies, medical devices, software and research products. Innovation is driven by AI-powered machine learning and high throughput laboratory testing.

​